Literature DB >> 27598018

AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future Directions.

Jonathan A Drezner1, Francis G OʼConnor, Kimberly G Harmon, Karl B Fields, Chad A Asplund, Irfan M Asif, David E Price, Robert J Dimeff, David T Bernhardt, William O Roberts.   

Abstract

Cardiovascular (CV) screening in young athletes is widely recommended and routinely performed before participation in competitive sports. While there is general agreement that early detection of cardiac conditions at risk for sudden cardiac arrest and death (SCA/D) is an important objective, the optimal strategy for CV screening in athletes remains an issue of considerable debate. At the center of the controversy is the addition of a resting electrocardiogram (ECG) to the standard preparticipation evaluation using history and physical examination. The American Medical Society for Sports Medicine (AMSSM) formed a task force to address the current evidence and knowledge gaps regarding preparticipation CV screening in athletes from the perspective of a primary care sports medicine physician. The absence of definitive outcomes-based evidence at this time precludes AMSSM from endorsing any single or universal CV screening strategy for all athletes including legislative mandates. This statement presents a new paradigm to assist the individual physician in assessing the most appropriate CV screening strategy unique to their athlete population, community needs, and resources. The decision to implement a CV screening program, with or without the addition of ECG, necessitates careful consideration of the risk of SCA/D in the targeted population and the availability of cardiology resources and infrastructure. Importantly, it is the individual physician's assessment in the context of an emerging evidence base that the chosen model for early detection of cardiac disorders in the specific population provides greater benefit than harm. American Medical Society for Sports Medicine is committed to advancing evidenced-based research and educational initiatives that will validate and promote the most efficacious strategies to foster safe sport participation and reduce SCA/D in athletes.

Entities:  

Mesh:

Year:  2016        PMID: 27598018     DOI: 10.1097/JSM.0000000000000382

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  9 in total

1.  Vectorcardiogram in athletes: The Sun Valley Ski Study.

Authors:  Jason A Thomas; Erick A Perez-Alday; Allison Junell; Kelley Newton; Christopher Hamilton; Yin Li-Pershing; David German; Aron Bender; Larisa G Tereshchenko
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-11-07       Impact factor: 1.468

2.  The Inter-Association Task Force Document on Emergency Health and Safety: Best-Practice Recommendations for Youth Sports Leagues.

Authors:  Robert A Huggins; Samantha E Scarneo; Douglas J Casa; Luke N Belval; Kate S Carr; George Chiampas; Michael Clayton; Ryan M Curtis; A J Duffy; Alexandra Flury; Matthew Gammons; Yuri Hosokawa; John F Jardine; Cynthia R LaBella; Rachael Oats; Jack W Ransone; Scott R Sailor; Katie Scott; Rebecca L Stearns; Lesley W Vandermark; Timothy Weston
Journal:  J Athl Train       Date:  2017-03-07       Impact factor: 2.860

3.  Increasing Primary Care Follow-up after Preparticipation Physical Evaluations.

Authors:  Melanie Kennedy; Frances Comer; Julie A Young; Amy E Valasek
Journal:  Pediatr Qual Saf       Date:  2020-10-26

Review 4.  Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes.

Authors:  Chaney G Stewman; Catherine Liebman; Laura Fink; Brad Sandella
Journal:  Sports Health       Date:  2017-11-16       Impact factor: 3.843

Review 5.  Sport and exercise participation in time of Covid-19-A narrative review of medical and health perspective.

Authors:  Milena Tomovic; Lana Krzman
Journal:  Transl Sports Med       Date:  2020-12-17

6.  Electro- and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Karolina Bula; Joanna Bisaga; Bartłomiej Feret; Michał Razik; Barbara Rozpiątkowska; Mateusz Tometczak; Katarzyna Mizia-Stec
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-07-19       Impact factor: 1.485

Review 7.  Preparticipation screening-the way forward is smart screening.

Authors:  H Thune Jørstad
Journal:  Neth Heart J       Date:  2018-03       Impact factor: 2.380

Review 8.  Sudden cardiac arrest on the field of play: turning tragedy into a survivable event.

Authors:  David M Siebert; Jonathan A Drezner
Journal:  Neth Heart J       Date:  2018-03       Impact factor: 2.380

9.  Cardiovascular Preparticipation Screening in Young Athletes: Looking Through One Lens.

Authors:  Irfan M Asif; Jonathan A Drezner; Francis G O'Connor
Journal:  Sports Health       Date:  2017 Jan/Feb       Impact factor: 3.843

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.